Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2016 (2016), Article ID 9751736, 4 pages
http://dx.doi.org/10.1155/2016/9751736
Case Report

Plasmablastic Lymphoma Mimicking Acute Pancreatitis

1Department of Medicine, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10065, USA
2Department of Medicine, Mount Sinai St. Luke’s and Mount Sinai Roosevelt Hospitals, Icahn School of Medicine, New York, NY 10019, USA
3Department of Hematology/Oncology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA

Received 8 November 2015; Accepted 22 December 2015

Academic Editor: Josep M. Ribera

Copyright © 2016 Faisal Inayat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Delecluse, I. Anagnostopoulos, F. Dallenbach et al., “Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection,” Blood, vol. 89, no. 4, pp. 1413–1420, 1997. View at Google Scholar · View at Scopus
  2. J. J. Castillo, M. Bibas, and R. N. Miranda, “The biology and treatment of plasmablastic lymphoma,” Blood, vol. 125, no. 15, pp. 2323–2330, 2015. View at Publisher · View at Google Scholar
  3. J. J. Liu, L. Zhang, E. Ayala et al., “Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review,” Leukemia Research, vol. 35, no. 12, pp. 1571–1577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Riedel, L. F. Gonzalez-Cuyar, X. F. Zhao, R. R. Redfield, and B. L. Gilliam, “Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection,” The Lancet Infectious Diseases, vol. 8, no. 4, pp. 261–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Haramura, M. Haraguchi, J. Irie, S. Ito, H. Tokai, K. Noda et al., “Case of plasmablastic lymphoma of the sigmoid colon and literature review,” World Journal of Gastroenterology, vol. 21, no. 24, pp. 7598–7603, 2015. View at Publisher · View at Google Scholar
  6. Y. Takahashi, I. Saiga, J.-I. Fukushima et al., “Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient,” Pathology International, vol. 59, no. 12, pp. 868–873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Chuah, S. B. Ng, L. Poon, and W. M. Yap, “Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation,” International Journal of Surgical Pathology, vol. 17, no. 2, pp. 163–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Yasuhara, T. Irié, E. Shiozawa et al., “Plasmablastic lymphoma of the maxillary sinus with intraoral manifestation caused by direct alveolar bone infiltration in an HIV-negative patient,” Pathology International, vol. 64, no. 11, pp. 588–590, 2014. View at Publisher · View at Google Scholar
  9. H. Metta, M. Corti, A. Maranzana, R. Schtirbu, M. Narbaitz, and M. De Dios Soler, “Unusual case of plasmablastic non-hodgkin's lymphoma located in the liver. First case reported in an AIDS patient,” Annals of Hepatology, vol. 8, no. 3, pp. 242–245, 2009. View at Google Scholar · View at Scopus
  10. P. A. R. Urrego, M. Smethurst, M. Fowkes et al., “Primary CNS plasmablastic lymphoma: report of a case with CSF cytology, flow cytometry, radiology, histological correlation, and review of the literature,” Diagnostic Cytopathology, vol. 39, no. 8, pp. 616–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Castillo, E. S. Winer, D. Stachurski et al., “Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma,” Leukemia and Lymphoma, vol. 51, no. 11, pp. 2047–2053, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Morscio, D. Dierickx, J. Nijs et al., “Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases,” American Journal of Surgical Pathology, vol. 38, no. 7, pp. 875–886, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Schommers, M. Hentrich, C. Hoffmann et al., “Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort,” British Journal of Haematology, vol. 168, no. 6, pp. 806–810, 2015. View at Publisher · View at Google Scholar
  14. G. Elyamany, A. M. Alzahrani, M. Aljuboury et al., “Clinicopathologic features of plasmablastic lymphoma: single-center series of 8 cases from Saudi Arabia,” Diagnostic Pathology, vol. 10, article 78, 2015. View at Publisher · View at Google Scholar
  15. S. P. Perrine, O. Hermine, T. Small et al., “A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies,” Blood, vol. 109, no. 6, pp. 2571–2578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Friis, B. Åkerlund, B. Christensson et al., “Epstein Barr virus DNA analysis in blood predicts disease progression in a rare case of plasmablastic lymphoma with effusion,” Infectious Agents and Cancer, vol. 8, article 28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. Law, W. L. Poon, K. S. Ng et al., “Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma,” Annals of Hematology, vol. 91, no. 5, pp. 789–791, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Campo, S. H. Swerdlow, N. L. Harris, S. Pileri, H. Stein, and E. S. Jaffe, “The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications,” Blood, vol. 117, no. 19, pp. 5019–5032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Vega, C.-C. Chang, L. J. Medeiros et al., “Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles,” Modern Pathology, vol. 18, no. 6, pp. 806–815, 2005. View at Publisher · View at Google Scholar
  20. A. Valera, O. Balagué, L. Colomo et al., “IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas,” American Journal of Surgical Pathology, vol. 34, no. 11, pp. 1686–1694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Y. Dong, D. T. Scadden, L. de Leval, Z. Tang, P. G. Isaacson, and N. L. Harris, “Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm,” The American Journal of Surgical Pathology, vol. 29, no. 12, pp. 1633–1641, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Castillo and J. L. Reagan, “Plasmablastic lymphoma: a systematic review,” TheScientificWorldJOURNAL, vol. 11, pp. 687–696, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Castillo, J. L. Reagan, W. M. Sikov, and E. S. Winer, “Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma,” British Journal of Haematology, vol. 169, no. 3, pp. 352–355, 2015. View at Publisher · View at Google Scholar · View at Scopus